Controllab expands portfolio for neonatal screening in August


Those interested in participating in the pilot round can sign up for participation until July 23rd

“Neonatal heel prick” is the popular name given to the Guthrie Test, carried out with the aim of early diagnosis in newborns of some diseases that can cause serious complications over the years.

On May 26, 2021, in Brazil, Law nº 14.154/2021 was enacted, which increases the number of diseases detectable by the heel prick test performed on newborns to improve the National Neonatal Screening Program (PNTN).

Issuing reliable reports for screening analyzes is essential with a focus on prevention, early intervention and permanent monitoring of individuals detected with the diseases. Performing Proficiency Testing (PT) – also known as External Quality Control – regularly and in conjunction with the application of Internal Control, promotes reliability in analytical routines.

Controllab has External and Internal Control for Neonatal Screening and, in August, this scope will be expanded with the inclusion of new tests:

• MCAD deficiency
• Lysosomal Diseases
• Acylcarnitines Profile

Currently, there are controls for the following area exams:

• 17OH Progesterone
• Amino acids
• Anti-Cytomegalovirus IgM
• Anti-HIV
• Anti-Rubella IgM
• Anti-Toxoplasma IgM
• Anti-Trypanosoma cruzi
• Biotinidase Activity
• G6PD Activity
• Assessment of Hemoglobins
• Phenylalanine (PKU)
• Total Galactose
• T4
• Immunoreactive trypsin

Those interested in participating in the pilot round, which will be sent free of charge on August 9th, can choose to participate in this link until July 23rd.

All tests offered by Controllab follow the criteria of ABNT NBR ISO/IEC 17043. By participating in the PT, the laboratory will be able to evidence the accuracy of the analyzes and the reliability of the results issued in its routine.

To learn more, access the Controllab website, contact us by e-mail customer or by phone +55 (21) 3891 9900.

Sign up for our newsletter

Receive relevant publications about labs, solutions for quality
management and optimization of business management.


acesso ao sitema

Estamos enfrentando alguns problemas de acesso ao sistema, pedimos a compreensão de todos. Tente novamente em alguns minutos.


We use cookies and other similar technologies to improve your experience, enabling a more personalized navigation, according to the characteristics and your interest.

For more information see our Privacy and Security Policy.

PRM 0009

Accreditation Cgcre/Inmetro - Certified Reference Material Producer

Controllab has been accredited as a Certified Reference Material Producer (MRC) since 2016 by Inmetro’s General Coordination for Accreditation (CGCRE), under the PMR 0009 number. The assessment of this conformity is carried out according to the requirements established in ABNT NBR standards ISO 17034 and Inmetro, thus ensuring competence for the production of MRCs, according to the Scope of Accreditation.

CAL 0214

Accreditation Cgcre/Inmetro - Calibration Laboratory

In December 2002, the Calibration Laboratory was accredited by Inmetro’s General Coordination for Accreditation (CGCRE). With this recognition, it became an integral part of the Brazilian network of accredited laboratories, under nº214. Since then, it is periodically evaluated for the maintenance and/or extension of accreditation.

PEP 0003

Accreditation Cgcre/Inmetro - Control Laboratory

In September 2011, Controllab was accredited by Inmetro’s General Coordination for Accreditation (CGCRE) as a proficiency test provider, under nº PEP0003. Initially as part of a pilot project by Inmetro, this accreditation was based on ILAC G13: 2007 and included several clinical and hemotherapy tests. In the periodic evaluations of this accreditation, new segments and tests are included and the evaluation is now conducted according to ABNT NBR ISO/IEC 17043.

This accreditation attests to Controllab’s technical competence to develop and conduct proficiency tests in accordance with international requirements and enables it to be recognized in other countries, in accordance with mutual recognition agreements signed by Brazil in Mercosur, the Americas and Europe.